IBD Study: Recruitment
Thank you for your interest in our study, Engaging patient partners in designing research on patient preferences: Patient experiences with biologic medications for the treatment of IBD. This study has been reviewed by the University of Calgary Research Ethics Board (REB20-1563). Our research team is interested in learning more about the experiences that people with Inflammatory Bowel Disease (IBD) have managing their biologic treatment (biologic treatments are medications typically given by injection or IV, such as Remicade, Humera, Inflecta, etc.).
Please let us know how we can best reach you to tell you a little more about the study and answer any questions you may have.